Overview

Update
Status
Acquired by on July 30, 2013
Investments
1 Investment in 1 Company
Headquarters:
San Diego, CA
Description:
Optimer Pharmaceuticals, Inc. (Optimer) is a biopharmaceutical company focused on discovering, developing and commercializing
Categories:
Pharmaceutical, Therapeutics, Biotechnology
Website:
http://www.optimerpharma.com
Social:

Company Details

Update
Founded:
1998
Contact:
8589090737
Employees:
251 - 500 | 4 in Crunchbase

Optimer Pharmaceuticals, Inc. (Optimer) is a biopharmaceutical company focused on discovering, developing and commercializing anti-infective products. It has two late-stage anti-infective product candidates, fidaxomicin and Pruvel (prulifloxacin). Optimer's development efforts are focused on products that treat gastrointestinal infections, and related diseases where therapies have limitations. Its product portfolio includes Fidaxomicin, Pruvel, CEM-101, OPT-822/OPT-821 Combination Therapy and OPT-88.

Funding Rounds (2) - $34.2M

Update
DateAmount / RoundValuationLead InvestorInvestors
Dec, 2005$22.2M / Series D8
Mar, 2005$12M / Venture1

Investments (1)

DateInvested InRoundPartner(s)
Jul, 2007$10M / Series B

Current Team (4)

Update

Board Members and Advisors (1)

Update

Offices/Locations (2)

Update
  • Office

    10110 Sorrento Valley Rd.

    Suite C

    San Diego, CA 92121

    USA

  • Headquarters

    65 Hayden Avenue

    Lexington, MA 02421

    USA

Past Team (3)

Update

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos